Abbott Laboratories (ABT)

traders view logo Charts by TradingView

Pricing is indicative. Past performance is not a reliable indicator of future results. Log in to see latest markets data.

Abbott Laboratories (ABT) Profile

Abbott Laboratories (ABT.xnys) is a multinational medical devices and health care company headquartered in Abbott Park, Illinois, America. Abbott sells medical devices, diagnostics, branded generic medicines and nutritional products, and its well-known products are Pedialyte, Similac, Ensure, Glucerna, ZonePerfect, FreeStyle Libre, i-STAT and MitraClip. The company operates in over 160 countries and employs 109,000 people. Due to the COVID-19 pandemic, Abbott delivered more than 400M tests at the beginning and 300M in the fourth quarter of 2020. Abbott has been an important key for detecting the complex virus and getting patients treatment but also brought faster testing with a low-cost rapid antigen test that helped schools and workplaces reopen earlier. The Abbott Laboratories stock (ABT.xnys) is listed on the New York Stock Exchange (NYSE), had a market capitalisation of $240.08B (USD) as of January 2022 and $34.61B in 2020 yearly revenue. Abbott, after the acquisition of WALK Vascular in September 2021, announced that the Food and Drug Administration (FDA) had approved new expanded magnetic resonance imaging (MRI) compatibility for its Proclaim XR Spinal Cord Stimulation (SCS) System with Octrode leads.

Holding cost
Long
-5%
Short
-2.5%
Trading hours in US Eastern Time
Fri
16:30-23:00
Mon
16:30-23:00
Tue
16:30-23:00
Wed
16:30-23:00
Thu
16:30-23:00
Sun
Closed
Sat
Closed

Share CFD Trading FAQ

Each investor owning shares of a company is also owning fragments of the company. A quite simple way to explain what a stock is is basically when a company divides itself into several shares and then it makes a part of these equities available to the public, at a price. Each investor owning shares of a company is owning fragments of the company.

While shares represent units of ownership within a company Contracts for Difference (CFDs) allow traders to speculate on the future share price fluctuations of an underlying asset. Thus when trading CFDs traders do not physically own the underlying asset. CFDs are available for a range of underlying assets, such as shares, commodities, and foreign exchange, and indices.

Why Trade Abbott Laboratories (ABT) with FP Markets? An Australian-regulated forex & CFD broker
go long or short
Go Long or Short

Increase your ability to profit in
all market conditions
Leverage options up to 20:1

direct market access
Direct Market Access (DMA) Execution

Real-time, transparent share prices
Control, Functionality and deep liquidity
Full Market depth & see your orders in the queue

advanced platforms
Advanced Platforms
& Technology

MT4, MT5, Webtrader & Iress with
superior client portal

24/5 Multilingual customer support
24/5 Multilingual
Customer Support

Award winning support &
personal account managers

global exposure
Global Exposure

Low margins and competitive commission
+10,000 products on global stocks
across 4 continents

earn dividends
Earn Dividends

On long positions
No ownership of physical
shares necessary

Start Trading
in Minutes

bullet Access 10,000+ financial instruments
bullet Auto open & close positions
bullet News & economic calendar
bullet Technical indicators & charts
bullet Many more tools included

By supplying your email you agree to FP Markets privacy policy and receive future marketing materials from FP Markets. You can unsubscribe at any time.




Source - cache | Page ID - 671

Get instant Updates in Telegram